NO178362C - Fremgangsmåte for fremstilling av tabletter og granulat inneholdende mesna som virksomt stoff - Google Patents

Fremgangsmåte for fremstilling av tabletter og granulat inneholdende mesna som virksomt stoff

Info

Publication number
NO178362C
NO178362C NO912771A NO912771A NO178362C NO 178362 C NO178362 C NO 178362C NO 912771 A NO912771 A NO 912771A NO 912771 A NO912771 A NO 912771A NO 178362 C NO178362 C NO 178362C
Authority
NO
Norway
Prior art keywords
weight
parts
tablets
preparation
mesna
Prior art date
Application number
NO912771A
Other languages
English (en)
Other versions
NO912771L (no
NO912771D0 (no
NO178362B (no
Inventor
Dieter Sauerbier
Juergen Prof Dr Engel
Eckhard Dr Milsmann
Original Assignee
Asta Medica Ag
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag, Asta Pharma Ag filed Critical Asta Medica Ag
Publication of NO912771D0 publication Critical patent/NO912771D0/no
Publication of NO912771L publication Critical patent/NO912771L/no
Publication of NO178362B publication Critical patent/NO178362B/no
Publication of NO178362C publication Critical patent/NO178362C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Glanulating (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO912771A 1990-07-16 1991-07-15 Fremgangsmåte for fremstilling av tabletter og granulat inneholdende mesna som virksomt stoff NO178362C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4022525 1990-07-16
SG142394A SG142394G (en) 1990-07-16 1994-10-03 Tablet and granulate containing mesna as active agent

Publications (4)

Publication Number Publication Date
NO912771D0 NO912771D0 (no) 1991-07-15
NO912771L NO912771L (no) 1992-01-17
NO178362B NO178362B (no) 1995-12-04
NO178362C true NO178362C (no) 1996-03-13

Family

ID=25895027

Family Applications (1)

Application Number Title Priority Date Filing Date
NO912771A NO178362C (no) 1990-07-16 1991-07-15 Fremgangsmåte for fremstilling av tabletter og granulat inneholdende mesna som virksomt stoff

Country Status (31)

Country Link
US (1) US5262169A (no)
EP (1) EP0468245B1 (no)
JP (1) JP3068894B2 (no)
KR (1) KR100189666B1 (no)
CN (1) CN1072484C (no)
AT (1) ATE104548T1 (no)
AU (1) AU638586B2 (no)
BG (2) BG60851B1 (no)
CA (1) CA2047027C (no)
DE (2) DE4122167A1 (no)
DK (1) DK0468245T3 (no)
EG (1) EG20019A (no)
ES (1) ES2063412T3 (no)
FI (1) FI97949C (no)
HK (1) HK129894A (no)
HR (1) HRP920889B1 (no)
HU (1) HU206630B (no)
IE (1) IE65373B1 (no)
IL (1) IL98836A (no)
LT (1) LT3527B (no)
LV (1) LV10040B (no)
MC (1) MC2273A1 (no)
MX (1) MX174407B (no)
NO (1) NO178362C (no)
NZ (1) NZ238941A (no)
PT (1) PT98325B (no)
RO (1) RO113713B1 (no)
RU (1) RU2070040C1 (no)
SG (1) SG142394G (no)
SI (1) SI9111226A (no)
ZA (1) ZA915515B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE160696T1 (de) * 1992-03-11 1997-12-15 Asta Medica Ag Tabletten, granulate und pellets mit hohem gehalt an wirkstoffen für hochkonzentrierte, feste darreichungsformen
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
DE19733305A1 (de) * 1997-08-01 1999-02-04 Asta Medica Ag Pharmazeutische Zusammensetzung enthaltend Ifosfamid und Carnitin
EP0955040A1 (de) * 1998-04-27 1999-11-10 ASTA Medica Aktiengesellschaft Arzneiform zur oralen Applikation von Mesna
DE19826517B4 (de) * 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette
US6075053A (en) * 1999-02-09 2000-06-13 Bionumerik Pharmaceuticals, Inc. Method of reducing or reversing neuropathy
WO2009022430A1 (en) * 2007-08-10 2009-02-19 Ki Pharmaceuticals, Inc. Skin whitening agent
CA2936746C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734418A (en) * 1984-12-14 1988-03-29 Mitsui Petrochemical Industries, Ltd. Quinazoline compounds and antihypertensives
IT1185551B (it) * 1985-04-15 1987-11-12 Schering Spa Composizioni farmaceutiche a base di acido mercaptoetansolfonico ad attivita' terapeutica,derivati salini organici dell'acido mercaptoetansolfonico utili per tali composizioni e relativo procedimento di preparazione
EP0334083B1 (de) * 1988-03-19 1991-07-24 ASTA Pharma Aktiengesellschaft Ifosfamid-Mesna-Lyophilisat und Verfahren zu dessen Herstellung

Also Published As

Publication number Publication date
MX174407B (es) 1994-05-13
DE4122167A1 (de) 1992-01-23
NO912771L (no) 1992-01-17
KR920002154A (ko) 1992-02-28
IL98836A (en) 1994-11-28
HUT59317A (en) 1992-05-28
PT98325B (pt) 1999-01-29
RU2070040C1 (ru) 1996-12-10
ZA915515B (en) 1992-04-29
BG96200A (bg) 1993-12-24
SI9111226A (en) 1995-04-30
ATE104548T1 (de) 1994-05-15
BG94824A (bg) 1993-12-24
HU206630B (en) 1992-12-28
EP0468245A1 (de) 1992-01-29
FI913409A0 (fi) 1991-07-15
FI913409A (fi) 1992-01-17
IE65373B1 (en) 1995-10-18
KR100189666B1 (ko) 1999-06-01
LV10040B (en) 1995-06-20
HK129894A (en) 1994-12-02
BG60851B1 (bg) 1996-05-31
NO912771D0 (no) 1991-07-15
DE59101431D1 (de) 1994-05-26
CN1072484C (zh) 2001-10-10
BG60901B1 (bg) 1996-06-28
EP0468245B1 (de) 1994-04-20
IL98836A0 (en) 1992-07-15
FI97949C (fi) 1997-03-25
EG20019A (en) 1997-01-30
PT98325A (pt) 1992-05-29
DK0468245T3 (da) 1994-05-16
LV10040A (lv) 1994-05-10
RO113713B1 (ro) 1998-10-30
IE912463A1 (en) 1992-01-29
CN1058337A (zh) 1992-02-05
NZ238941A (en) 1993-03-26
ES2063412T3 (es) 1995-01-01
AU8044591A (en) 1992-01-16
JP3068894B2 (ja) 2000-07-24
US5262169A (en) 1993-11-16
LTIP920A (en) 1995-03-27
CA2047027A1 (en) 1992-01-17
JPH04230319A (ja) 1992-08-19
NO178362B (no) 1995-12-04
FI97949B (fi) 1996-12-13
MC2273A1 (fr) 1993-06-23
LT3527B (en) 1995-11-27
HU912374D0 (en) 1991-12-30
HRP920889A2 (en) 1996-04-30
HRP920889B1 (en) 1998-02-28
SG142394G (en) 1995-01-13
CA2047027C (en) 1996-09-17
AU638586B2 (en) 1993-07-01

Similar Documents

Publication Publication Date Title
GR3004643T3 (no)
DK0560092T3 (da) Tabletter, granulater og pellets med højt indholdaf aktivstoffer til højkoncentrerede, faste administreringsformer
ES2061623T3 (es) Procedimiento para la obtencion de una composicion farmaceutica y un granulado farmaceutico.
GT198303076A (es) Formulaciones de pastillas de accion prolongada con disolucion paulatina.
NO178362C (no) Fremgangsmåte for fremstilling av tabletter og granulat inneholdende mesna som virksomt stoff
NZ337418A (en) Paracetamol composition with improved rate of absorption
DE2963990D1 (en) Analgesic tablet and process for its preparation
ES551435A0 (es) Proceso para la fabricacion de compuestos de espiro-hidantoina
WO1987000432A3 (en) Use of melatonin or related compounds for the treatment of psoriasis
GB2021409A (en) Pharmaceutical composition
YU122691A (sh) Tablete i granulat koji kao aktivnu materiju sadrže natrijum-2-merkapto-etansulfonat
JPS52130905A (en) Medicinal composition
JPS5344617A (en) Drug composition
JPS5251032A (en) Medicines of disaccharide-glutathione derivatives
SE8401856D0 (sv) New pharmaceutical preparations
KR920000316A (ko) 젬피브로질 제제
YU46792B (sh) Kipuća tableta za dezinfekciju vode na bazi hloramina i postupak za njihovu proizvodnju
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives
JPS56147715A (en) Anticataractal agent
KR930007451A (ko) 우리딘을 유효성분으로 함유하는 관절염 치료제
KR840001829A (ko) 새로운 이펜프로딜을 함유하는 정제의 제조방법
TH13475A (th) สูตรผสมทางเภสัชกรรม

Legal Events

Date Code Title Description
MK1K Patent expired